Validation of an obstetric comorbidity index in an external population

被引:123
|
作者
Metcalfe, A. [1 ]
Lix, L. M. [2 ]
Johnson, J-A [1 ]
Currie, G. [3 ,4 ]
Lyon, A. W. [5 ]
Bernier, F. [6 ]
Tough, S. C. [3 ,4 ]
机构
[1] Univ Calgary, Dept Obstet & Gynaecol, Calgary, AB, Canada
[2] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada
[3] Univ Calgary, Dept Paediat, Calgary, AB T2N 1N4, Canada
[4] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[5] Univ Saskatchewan, Dept Pathol & Lab Med, Saskatoon Hlth Reg & Coll Med, Saskatoon, SK, Canada
[6] Univ Calgary, Dept Clin Genet, Calgary, AB, Canada
基金
加拿大健康研究院;
关键词
Comorbidity; International Classification of Diseases; pregnancy; prevalence; validation; HOSPITAL DISCHARGE DATA; PREGNANCY-ASSOCIATED HOSPITALIZATIONS; MATERNAL MEDICAL CONDITIONS; UNITED-STATES; MORBIDITY; COMPLICATIONS; PERFORMANCE; INFORMATION; PREVALENCE; IMPACT;
D O I
10.1111/1471-0528.13254
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
ObjectivesAn obstetric comorbidity index has been developed recently with superior performance characteristics relative to general comorbidity measures in an obstetric population. This study aimed to externally validate this index and to examine the impact of including hospitalisation/delivery records only when estimating comorbidity prevalence and discriminative performance of the obstetric comorbidity index. DesignValidation study. SettingAlberta, Canada. PopulationPregnant women who delivered a live or stillborn infant in hospital (n=5995). MethodsAdministrative databases were linked to create a population-based cohort. Comorbid conditions were identified from diagnoses for the delivery hospitalisation, all hospitalisations and all healthcare contacts (i.e. hospitalisations, emergency room visits and physician visits) that occurred during pregnancy and 3months pre-conception. Logistic regression was used to test the discriminative performance of the comorbidity index. Main outcome measuresMaternal end-organ damage and extended length of stay for delivery. ResultsAlthough prevalence estimates for comorbid conditions were consistently lower in delivery records and hospitalisation data than in data for all healthcare contacts, the discriminative performance of the comorbidity index was constant for maternal end-organ damage [all healthcare contacts area under the receiver operating characteristic curve (AUC)=0.70; hospitalisation data AUC=0.67; delivery data AUC=0.65] and extended length of stay for delivery (all healthcare contacts AUC=0.60; hospitalisation data AUC=0.58; delivery data AUC=0.58). ConclusionsThe obstetric comorbidity index shows similar performance characteristics in an external population and is a valid measure of comorbidity in an obstetric population. Furthermore, the discriminative performance of the comorbidity index was similar for comorbidities ascertained at the time of delivery, in hospitalisation data or through all healthcare contacts.
引用
收藏
页码:1748 / 1755
页数:8
相关论文
共 50 条
  • [41] DEVELOPMENT AND VALIDATION OF THE MODIFIED CHARLSON COMORBIDITY INDEX IN INCIDENT PERITONEAL DIALYSIS PATIENTS: A NATIONAL POPULATION-BASED APPROACH
    Cho, Hyunjeong
    Kim, Myoung-Hee
    Kim, Hyo Jin
    Park, Jae Yoon
    Ryu, Dong-Ryeol
    Lee, Hajeong
    Lee, Jung Pyo
    Lim, Chun-Soo
    Kim, Kyoung Hoon
    Oh, Kook-Hwan
    Joo, Kwon Wook
    Kim, Yon Su
    Kim, Dong Ki
    PERITONEAL DIALYSIS INTERNATIONAL, 2017, 37 (01): : 94 - 102
  • [42] Validation of the Barthel Index in the Spanish population
    Bernaola-Sagardui, Irati
    ENFERMERIA CLINICA, 2018, 28 (03): : 210 - 211
  • [43] External Validation of and Factors Associated with the Overuse Index: a Nationwide Population-Based Study from Taiwan
    Yu-Chi Tung
    Guo-Hong Li
    Hsien-Yen Chang
    Journal of General Internal Medicine, 2021, 36 : 438 - 446
  • [44] External Validation of and Factors Associated with the Overuse Index: a Nationwide Population-Based Study from Taiwan
    Tung, Yu-Chi
    Li, Guo-Hong
    Chang, Hsien-Yen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (02) : 438 - 446
  • [45] The DANish Comorbidity Index for Acute Myocardial Infarction (DANCAMI): Development, Validation and Comparison with Existing Comorbidity Indices
    Albertsen, Lisbeth Wellejus
    Heide-Jorgensen, Uffe
    Schmidt, Sigrun Alba Johannesdottir
    Grey, Corina
    Jackson, Rod
    Sorensen, Henrik Toft
    Schmidt, Morten
    CLINICAL EPIDEMIOLOGY, 2020, 12 : 1299 - 1311
  • [46] Comorbidity index development in a head and neck cancer population.
    Reid, BC
    Winn, DM
    Garcia, AI
    Rozier, RG
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 458 - 458
  • [47] The development and validation of a comorbidity index for prostate cancer among Black men
    Fleming, ST
    Pearce, KA
    McDavid, K
    Pavlov, D
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (11) : 1064 - 1075
  • [48] Development and validation of a self-administered index of musculoskeletal comorbidity.
    Katz, JN
    Wright, EA
    Losina, E
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S660 - S660
  • [49] Recalibration and Validation of the Charlson Comorbidity Index in Korean Incident Hemodialysis Patients
    Park, Jae Yoon
    Kim, Myoung-Hee
    Han, Seung Seok
    Cho, Hyunjeong
    Kim, Ho
    Ryu, Dong-Ryeol
    Kim, Hyunwook
    Lee, Hajeong
    Lee, Jung Pyo
    Lim, Chun-Soo
    Kim, Kyoung Hoon
    Joo, Kwon Wook
    Kim, Yon Su
    Kim, Dong Ki
    PLOS ONE, 2015, 10 (05):
  • [50] Development and validation of a structured query language implementation of the Elixhauser comorbidity index
    Epstein, Richard H.
    Dexter, Franklin
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2017, 24 (04) : 845 - 850